ADMA Biologics, Inc. (ADMA)

ADMA Biologics Revenue

ADMA Biologics had revenue of $114.80M in the quarter ending March 31, 2025, with 40.22% growth. This brings the company's revenue in the last twelve months to $459.38M, up 62.22% year-over-year. In the year 2024, ADMA Biologics had annual revenue of $426.45M with 65.15% growth.

• Revenue (ttm): $459.38M
• Revenue Growth: +62.22%
• P/S Ratio: 10.09
• Revenue / Employee: $670,629
• Employees: 685
• Market Cap: 4.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	426.45M	168.24M	65.15%
Dec 31, 2023	258.22M	104.13M	67.59%
Dec 31, 2022	154.08M	73.14M	90.36%
Dec 31, 2021	80.94M	38.72M	91.72%
Dec 31, 2020	42.22M	12.87M	43.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.